Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Shi

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|January 7, 2015
Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimizationLele Zhao, Yingqing Wang, Danyan Cao, et al.
Nature Communications|August 20, 2025
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomicsMartin Steger, Gisele Nishiguchi, Qiong Wu, et al.
Biological Reviews of the Cambridge Philosophical Society|December 14, 2020
Human torpor: translating insights from nature into manned deep space expeditionZhe Shi, Meng Qin, Lu Huang, et al.
Nature|December 11, 2024
Continuous collective analysis of chemical reactionsMaowei Hu, Lei Yang, Nathaniel Twarog, et al.
Journal of Nanobiotechnology|April 29, 2023
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variantsZhi Chen, Chenshuo Wu, Yuxuan Yuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 22, 2023
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRAS<sup>G12C</sup> in Patients With NSCLC: Phase 1 Study ResultsZiming Li, Zhengbo Song, Yanqiu Zhao, et al.
Nanophotonics (Berlin, Germany)|February 20, 2025
Artificial intelligence driven Mid-IR photoimaging device based on van der Waals heterojunctions of black phosphorusZiqian Wang, Huide Wang, Chen Wang, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trialJianzhong Zhang, Cheng Zhou, Guoying Miao, et al.
Biological Reviews of the Cambridge Philosophical Society|August 27, 2025
Neuroplasticity and brain health: insights from natural torporZhe Shi, Xue-Min Wang, Wen-Wen Duan, et al.
Signal Transduction and Targeted Therapy|June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationDan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|January 7, 2015
Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimizationLele Zhao, Yingqing Wang, Danyan Cao, et al.
Nature Communications|August 20, 2025
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomicsMartin Steger, Gisele Nishiguchi, Qiong Wu, et al.
Biological Reviews of the Cambridge Philosophical Society|December 14, 2020
Human torpor: translating insights from nature into manned deep space expeditionZhe Shi, Meng Qin, Lu Huang, et al.
Nature|December 11, 2024
Continuous collective analysis of chemical reactionsMaowei Hu, Lei Yang, Nathaniel Twarog, et al.
Journal of Nanobiotechnology|April 29, 2023
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variantsZhi Chen, Chenshuo Wu, Yuxuan Yuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 22, 2023
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRAS<sup>G12C</sup> in Patients With NSCLC: Phase 1 Study ResultsZiming Li, Zhengbo Song, Yanqiu Zhao, et al.
Nanophotonics (Berlin, Germany)|February 20, 2025
Artificial intelligence driven Mid-IR photoimaging device based on van der Waals heterojunctions of black phosphorusZiqian Wang, Huide Wang, Chen Wang, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trialJianzhong Zhang, Cheng Zhou, Guoying Miao, et al.
Biological Reviews of the Cambridge Philosophical Society|August 27, 2025
Neuroplasticity and brain health: insights from natural torporZhe Shi, Xue-Min Wang, Wen-Wen Duan, et al.
Signal Transduction and Targeted Therapy|June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationDan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Pageof 28